CVS Pharmacy Inc., and its related corporate entities known as CVS collectively, agreed to pay $315 million to resolve allegations that they illegally filled opioid prescriptions and other controlled substances and sought payment for invalid prescriptions from federal healthcare programs in violation of the False Claims Act. The settlement resolves allegations in the government’s complaint that CVS knowingly filled prescriptions for controlled substances that lacked a legitimate medical purpose, were not valid, and/or were not issued in the usual course of professional practice. The VA OIG investigated this case with several other federal and state law enforcement agencies.
Data Dashboard
Reports and Recommendations Published Within the Last 12 Months
The numbers totaled above are for published reports and recommendations only; the investigations and procurement-sensitive contract review totals can be found in the Semiannual Reports to Congress.